PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Experimental Pediatrics10.3345/cep.2022.004372022659453-458Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in ThailandKunanya Suwannaying, Piti Techavichit, Patcharee Komvilaisak, Napat Laoaroon, Nattee Narkbunnam, Kleebsabai Sanpakit, Kanhatai Chiengthong, Thirachit Chotsampancharoen, Lalita Sathitsamitphong, Chalongpon Santong, Panya Seksarn, Suradej Hongeng, Surapon Wiangnonhttp://e-cep.org/upload/pdf/cep-2022-00437.pdf, http://e-cep.org/journal/view.php?doi=10.3345/cep.2022.00437, http://e-cep.org/upload/pdf/cep-2022-00437.pdf
Bone Marrow Transplantation10.1038/sj.bmt.17009321997207543-551Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescueSL Cohn, TJ Moss, M Hoover, HM Katzenstein, PR Haut, ER Morgan, AA Green, M Kletzelhttps://www.nature.com/articles/1700932.pdf, https://www.nature.com/articles/1700932, https://www.nature.com/articles/1700932.pdf
Frontiers in Endocrinology10.3389/fendo.2019.00555201910Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell RescuePauliina Utriainen, Anu Suominen, Outi Mäkitie, Kirsi Jahnukainenhttps://www.frontiersin.org/article/10.3389/fendo.2019.00555/full
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2013.12.2672014202S166High-Dose Chemotherapy with Busulfex and Melphalan As Conditioning Regimen Followed By Autologous STEM CELL Rescue for Pediatric Patients with High-Risk NeuroblastomaMenachem Bitan, Maram Abu-yaman, Nitzan Cohen-Newman, Ronit Elhasidhttps://api.elsevier.com/content/article/PII:S1083879113008380?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1083879113008380?httpAccept=text/plain
Cancer Treatment Reviews10.1016/s0305-7372(04)00120-32004306577-582Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma☆, ☆☆, ☆☆☆Abstracted from: Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–95.A GLASMACHERhttps://api.elsevier.com/content/article/PII:S0305737204001203?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737204001203?httpAccept=text/plain
Cancer Treatment Reviews10.1016/j.ctrv.2004.06.0042004306577-582Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphomaAxel Glasmacherhttps://api.elsevier.com/content/article/PII:S0305737204001203?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737204001203?httpAccept=text/plain
Clinical Breast Cancer10.1016/s1526-8209(11)70621-8200343173-175Update on High-Dose Adjuvant Chemotherapy and Autologous Stem Cell Rescue in Patients with High-Risk Breast CancerHeather DeGrendele, Joyce A. O'Shaughnessyhttps://api.elsevier.com/content/article/PII:S1526820911706218?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1526820911706218?httpAccept=text/plain
Biology of Blood and Marrow Transplantation10.1016/j.bbmt.2011.12.2632012182S306High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Rescue for Children with High-Risk Neuroblastoma. Experience of a Single Pediatric Center in Bogotá, ColombiaM. Chaparro, M. Estupinanhttps://api.elsevier.com/content/article/PII:S1083879111008238?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1083879111008238?httpAccept=text/plain
Pediatric Blood & Cancer10.1002/pbc.2503320146181350-1356Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastomaAlissa Martin, Jennifer Schneiderman, Irene B. Helenowski, Elaine Morgan, Kimberley Dilley, Karina Danner-Koptik, Mohamad Hatahet, Hiroyuki Shimada, Susan L. Cohn, Morris Kletzel, Nobuko Hijiyahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.25033, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.25033, http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25033/fullpdf
Pediatric Blood & Cancer10.1002/pbc.274212018661e27421Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescueMahmoud M. Elzembely, Ann E. Dahlberg, Navin Pinto, Kasey J. Leger, Eric J. Chow, Julie R. Park, Paul A. Carpenter, K. Scott Bakerhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.27421, http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27421/fullpdf